Back to Search Start Over

Maturation of Lymph Node Fibroblastic Reticular Cells from Myofibroblastic Precursors Is Critical for Antiviral Immunity

Authors :
Tim Sparwasser
Volker Thiel
Christian Perez-Shibayama
Lucas Onder
Thomas Rülicke
Cristina Gil-Cruz
Jovana Cupovic
Burkhard Ludewig
Renzo Danuser
Sanjiv A. Luther
Thomas Hehlgans
Jens V. Stein
Qian Chai
Elke Scandella
Source :
Immunity, Chai, Qian; Onder, Lucas; Scandella, Elke; Gil-Cruz, Cristina; Perez-Shibayama, Christian; Cupovic, Jovana; Danuser, Renzo; Sparwasser, Tim; Luther, Sanjiv A.; Thiel, Volker; Rülicke, Thomas; Stein, Jens Volker; Hehlgans, Thomas; Ludewig, Burkhard (2013). Maturation of lymph node fibroblastic reticular cells from myofibroblastic precursors is critical for antiviral immunity. Immunity, 38(5), pp. 1013-1024. Cell Press 10.1016/j.immuni.2013.03.012
Publication Year :
2013
Publisher :
Elsevier BV, 2013.

Abstract

SummaryThe stromal scaffold of the lymph node (LN) paracortex is built by fibroblastic reticular cells (FRCs). Conditional ablation of lymphotoxin-β receptor (LTβR) expression in LN FRCs and their mesenchymal progenitors in developing LNs revealed that LTβR-signaling in these cells was not essential for the formation of LNs. Although T cell zone reticular cells had lost podoplanin expression, they still formed a functional conduit system and showed enhanced expression of myofibroblastic markers. However, essential immune functions of FRCs, including homeostatic chemokine and interleukin-7 expression, were impaired. These changes in T cell zone reticular cell function were associated with increased susceptibility to viral infection. Thus, myofibroblasic FRC precursors are able to generate the basic T cell zone infrastructure, whereas LTβR-dependent maturation of FRCs guarantees full immunocompetence and hence optimal LN function during infection.

Details

ISSN :
10747613
Volume :
38
Issue :
5
Database :
OpenAIRE
Journal :
Immunity
Accession number :
edsair.doi.dedup.....2fd8058d348f0fd46fc676682e489097
Full Text :
https://doi.org/10.1016/j.immuni.2013.03.012